CENTOGENE mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. We integrate multiomic technologies with the CENTOGENE Biodatabank – providing dimensional analysis to guide the next generation of precision medicine. Our unique approach enables rapid and reliable diagnosis for patients, supports a more precise physician understanding of disease states, and accelerates and de-risks targeted pharma drug discovery, development, and commercialization.
How do we do this? By bringing together more than 400 individuals from 50 different countries at our headquarter in Rostock, Germany, as well as our offices in Berlin, Belgrade, and laboratory facilities in Cambridge, MA. Our employees are medical experts, scientists, IT professionals, bioinformaticians, technicians, researchers, project managers, and many more – and are all passionate about supporting our company vision: A world healed of all rare and neurodegenerative diseases.
CENTOGENE was founded in 2006 and through an IPO in 2019 listed as a public company at NASDAQ (CNTG).
Our CentoValues to resonate with are: We Care ׀ We Collaborate ׀ We Innovate ׀ We Deliver Excellence ׀ We Act With Integrity
v Meet Our Diverse and Dynamic Global Team